WeightWatchers Partners with Sequence for Clinical Weight Management Program

WeightWatchers, a well-known weight management company, is now offering a new clinical membership option for its members. While WeightWatchers itself does not directly sell or prescribe weight management medications, it has partnered with Sequence, a telehealth company specializing in weight management, to provide this service.

According to Dr. Spencer Nadolsky, Medical Director of WeightWatchers, current members interested in the clinical offering can complete an intake quiz to determine their eligibility for prescription weight-loss treatment. If deemed suitable, they can schedule a consultation with a Sequence clinician. These clinicians are all board-certified and undergo additional training before seeing patients.

Telehealth visits can be conducted via video or text, depending on state regulations. Clinicians can prescribe FDA-approved and non-FDA approved medications for weight management, such as injectable GLP-1 obesity medications, oral diabetes medications, and diet pills.

Membership to WeightWatchers’ clinical offering costs $99 per month and includes check-ins with clinicians, access to community support groups, and more. While GLP-1 medications can be expensive, the company notes that the cost of labs and non-GLP-1 medications are included in the membership.

Dr. Nadolsky emphasizes the importance of combining medication with nutrition and physical activity behavior modifications for effective weight management. He also mentions that if insurance does not cover certain medications, alternative options will be provided as part of the clinical offering membership.

Overall, WeightWatchers aims to shift the conversation on weight towards ‘weight health,’ focusing on overall health rather than just pounds lost. With this new clinical membership option, members have access to personalized weight management support to help them achieve their health goals.